Radiopharm Theranostics Limited

ASX:RAD Stock Report

Market Cap: AU$52.2m

Radiopharm Theranostics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:RAD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Dec 24BuyAU$241,063Riccardo CanevariIndividual7,776,402AU$0.031
05 Dec 24SellAU$43,035Paul HopperIndividual1,500,000AU$0.029
18 Oct 24BuyAU$9,348Ian TurnerIndividual333,864AU$0.028
13 Sep 24BuyAU$150,000Ian TurnerIndividual3,750,000AU$0.04
13 Sep 24BuyAU$40,000Leila AllandIndividual1,000,000AU$0.04
13 Sep 24BuyAU$150,000Riccardo CanevariIndividual3,750,000AU$0.04
13 Sep 24BuyAU$38,800Phillip HainsIndividual970,000AU$0.04
13 Sep 24BuyAU$22,000Hester LarkinIndividual550,000AU$0.04
23 Aug 24SellAU$2,122,587UBS Asset Management AGCompany63,361,184AU$0.034
22 Aug 24BuyAU$3,731UBS Asset Management AGCompany112,100AU$0.033
21 Aug 24BuyAU$4,873,247UBS Asset Management AGCompany123,331,549AU$0.04
21 Aug 24SellAU$339,681UBS Asset Management AGCompany9,243,991AU$0.037
16 Aug 24BuyAU$7,312Regal Partners LimitedCompany203,105AU$0.036
12 Aug 24SellAU$177,304Regal Partners LimitedCompany5,369,673AU$0.035
01 Jul 24BuyAU$2,189,420JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany54,545,160AU$0.05
01 Jul 24BuyAU$3,009,852Regal Partners LimitedCompany75,246,901AU$0.04
01 Jul 24SellAU$19,947JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany499,889AU$0.05
01 Jul 24BuyAU$23,885,042NanoMab Technology LimitedCompany597,130,727AU$0.04

Insider Trading Volume

Insider Buying: RAD insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of RAD?
Owner TypeNumber of SharesOwnership Percentage
Private Companies69,975,6223.22%
Public Companies149,625,1806.89%
Hedge Funds160,080,3337.37%
Individual Insiders228,165,18310.5%
Institutions233,185,06310.7%
General Public1,331,929,37561.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 484.7%.

Top Shareholders

Top 25 shareholders own 38.7% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.17%
JPMorgan Chase & Co, Brokerage and Securities Investments
177,585,973AU$4.3m0%no data
7.37%
Regal Partners Limited
160,080,333AU$3.8m0%0.11%
6.89%
Lantheus Holdings, Inc.
149,625,180AU$3.6m0%no data
6.8%
Paul Hopper
147,721,428AU$3.5m-1.01%no data
2.35%
UBS Asset Management AG
51,127,261AU$1.2m0%no data
1.99%
NanoMab Technology Limited
43,295,131AU$1.0m53%no data
1.5%
Danny Segman
32,500,000AU$780.0k306%no data
0.73%
Phillip Hains
15,956,632AU$383.0k155%no data
0.73%
Shared Office Services Pty Ltd
15,839,358AU$380.1k0%no data
0.62%
Riccardo Canevari
13,403,584AU$321.7k38.9%no data
0.23%
Ian Turner
4,955,292AU$118.9k7.22%no data
0.21%
Su-Ming Wong
4,532,158AU$108.8k0%no data
0.14%
Flocell Ab
3,123,880AU$75.0k0%no data
0.14%
Jcr Investments Co
3,010,000AU$72.2k0%no data
0.13%
Niv Dagan
2,900,862AU$69.6k0%no data
0.12%
Mann Beef Pty Ltd
2,601,000AU$62.4k0%no data
0.11%
Zerrin Investments Pty Ltd, Asset Management Arm
2,425,000AU$58.2k0%5.61%
0.098%
Hsuan Tseng Tzu
2,121,829AU$50.9k0%no data
0.097%
Humanndiagnostics GmbH
2,106,253AU$50.6k0%no data
0.094%
Scintilla Capital Pty Ltd
2,046,829AU$49.1k0%1.12%
0.057%
David Mozley
1,240,000AU$29.8k0%no data
0.049%
Leila Alland
1,071,740AU$25.7k1,390%no data
0.046%
Thomas Tulip
1,000,000AU$24.0k0%no data
0.03%
Hester Larkin
644,247AU$15.5k584%no data
0.0054%
Michael Baker
117,411AU$2.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 18:28
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Radiopharm Theranostics Limited is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter
Hunter DiamondDiamond Equity Research LLC
Justin WalshJonesTrading Institutional Services, LLC